Literature DB >> 23908527

Estimating disease prevalence and incidence using administrative data: some assembly required.

Michael M Ward.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23908527      PMCID： PMC4159744          DOI： 10.3899/jrheum.130675

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  15 in total

1.  Systemic lupus erythematosus in the Arctic region of Norway.

Authors:  H C Nossent
Journal:  J Rheumatol       Date:  2001-03       Impact factor: 4.666

2.  Estimating rare disease prevalence from administrative hospitalization databases.

Authors:  Michael M Ward
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

3.  Population-based lupus registries: advancing our epidemiologic understanding.

Authors:  S Sam Lim; Cristina Drenkard; W Joseph McCune; Charles G Helmick; Caroline Gordon; Peter Deguire; Rana Bayakly; Emily C Somers
Journal:  Arthritis Rheum       Date:  2009-10-15

Review 4.  Capture-recapture methods in epidemiology: methods and limitations.

Authors:  E B Hook; R R Regal
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

Review 5.  Systematic review and critical appraisal of validation studies to identify rheumatic diseases in health administrative databases.

Authors:  Jessica Widdifield; Jeremy Labrecque; Lisa Lix; J Michael Paterson; Sasha Bernatsky; Karen Tu; Noah Ivers; Claire Bombardier
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-09       Impact factor: 4.794

6.  Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.

Authors:  C Ståhl-Hallengren; A Jönsen; O Nived; G Sturfelt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

7.  Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort.

Authors:  A Voss; A Green; P Junker
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

8.  Incidence and prevalence of systemic lupus erythematosus in a district of north Italy.

Authors:  M Govoni; G Castellino; S Bosi; N Napoli; F Trotta
Journal:  Lupus       Date:  2006       Impact factor: 2.911

9.  Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population.

Authors:  S Gudmundsson; K Steinsson
Journal:  J Rheumatol       Date:  1990-09       Impact factor: 4.666

10.  Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland.

Authors:  T Helve
Journal:  Scand J Rheumatol       Date:  1985       Impact factor: 3.641
View more
  25 in total

1.  Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.

Authors:  Sudumpai Jarukitsopa; Deana D Hoganson; Cynthia S Crowson; Olayemi Sokumbi; Mark D Davis; Clement J Michet; Eric L Matteson; Hilal Maradit Kremers; Vaidehi R Chowdhary
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

2.  The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.

Authors:  Khalid Almutairi; Johannes Nossent; David Preen; Helen Keen; Charles Inderjeeth
Journal:  Rheumatol Int       Date:  2020-11-11       Impact factor: 2.631

3.  Prevalence and incidence of rheumatoid arthritis in Italy.

Authors:  Maurizio Rossini; Elisa Rossi; Davide Bernardi; Ombretta Viapiana; Davide Gatti; Luca Idolazzi; Cristian Caimmi; Marisa Derosa; Silvano Adami
Journal:  Rheumatol Int       Date:  2014-03-09       Impact factor: 2.631

4.  The Incidence of Chronic Limb-Threatening Ischemia in the Midland Region of New Zealand over a 12-Year Period.

Authors:  Odette Hart; Nicole Xue; Brittany Davis-Havill; Mark Pottier; Minesh Prakash; Sascha-Akito Reimann; Jasmin King; William Xu; Manar Khashram
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

5.  Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example.

Authors:  Eliza Kruger; Paul McNiven; Deborah Marsden
Journal:  Adv Ther       Date:  2022-06-08       Impact factor: 4.070

6.  Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.

Authors:  Matteo Piga; Laura Casula; Silvia Sanna; Daniela Perra; Alberto Floris; Antonello Antonelli; Alberto Cauli; Alessandro Mathieu
Journal:  Rheumatol Int       Date:  2015-07-26       Impact factor: 2.631

7.  Frequency and risk factors for naturally occurring Cushing's syndrome in dogs attending UK primary-care practices.

Authors:  I Schofield; D C Brodbelt; S J M Niessen; D B Church; R F Geddes; D G O'Neill
Journal:  J Small Anim Pract       Date:  2021-12-08       Impact factor: 1.669

8.  Disparities in neonatal abstinence syndrome and health insurance status: A statewide study using non-claims real-time surveillance data.

Authors:  Amna Umer; Christa Lilly; Candice Hamilton; Janine Breyel; Lindsay Allen; Ancilla Rompala; Carrie Moore; Patricia O'Dierno; Collin John
Journal:  Paediatr Perinat Epidemiol       Date:  2020-10-27       Impact factor: 3.103

9.  Work Fatigue in a Non-Deployed Military Setting: Assessment, Prevalence, Predictors, and Outcomes.

Authors:  Michael R Frone; Ann-Renee Blais
Journal:  Int J Environ Res Public Health       Date:  2019-08-13       Impact factor: 3.390

10.  Columbia Open Health Data, clinical concept prevalence and co-occurrence from electronic health records.

Authors:  Casey N Ta; Michel Dumontier; George Hripcsak; Nicholas P Tatonetti; Chunhua Weng
Journal:  Sci Data       Date:  2018-11-27       Impact factor: 6.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.